Advertisement

Beyond the Surface: Monitoring your Patients with Moderate to Severe Plaque Psoriasis - Episode 3

Deucravacitinib Safety Data and Treatment Selection Considerations

Published on: 
,

Bruce Strober, MD, PhD, and Linda Stein Gold, MD, provide clinical insights on long-term safety data for deucravacitinib and selecting the right treatment for the right patient.

0:05 Long-term Safety Data of Deucravacitinib

6:55 Selecting the Right Treatment for the Right Patient

Advertisement
Advertisement